🇧🇷 Huluc63 in Brazil

Huluc63 (elotuzumab) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Huluc63 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Brazil

Frequently asked questions

Is Huluc63 approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Huluc63 in Brazil?

Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.